Collaborative Study Finds Low-Dose Thymoglobulin® Preserves Insulin Production in People Newly Diagnosed With Type 1 Diabetes

A TrialNet research study, funded by public and private organizations, found that low-dose Thymoglobulin® slows insulin loss in people newly diagnosed with type 1 diabetes. Thymoglobulin® is approved by the FDA for the prevention and treatment of acute r https://www.newswire.com/news/collaborative-study-finds-low-dose-thymoglobulin-preserves-insulin-20655059